Table A9.

The Impact of Exposure to Epidemic (18–25) on Confidence in Scientists – Country Level Heterogeneity.

	(1)	(2)	(3)	(4)	(5)	(6)
Outcome →	Confidence in scientists	Scientists working for private companies benefit the public	Scientists working for private companies are honest	Scientists working for universities benefit the public	Scientists working for universities are honest	Scientists to out accurate information
Sample → Countries with below median physicians per capita at the time of the epidemic
Exposure to Epidemic (18–25)	−2.538**	−0.941	−1.290	−1.480***	−3.821***	−1.500***
	(1.198)	(0.704)	(1.880)	(0.477)	(0.920)	(0.389)
Observations	23,471	22,897	21,429	22,657	21,188	23,457
Sample → Countries with above median physicians per capita at the time of the epidemic
Exposure to Epidemic (18–25)	8.534	3.150	23.543	3.551	−2.854	−10.120
	(8.792)	(19.549)	(19.378)	(17.570)	(20.983)	(15.787)
Observations	24,971	24,950	23,849	24,936	23,538	25,752
Sample → Countries with below median-income at the time of the epidemic
Exposure to Epidemic (18–25)	−3.385**	−1.205***	−2.169***	−0.653	−3.238***	−0.833
	(1.399)	(0.416)	(0.747)	(0.642)	(0.615)	(0.611)
Observations	32,979	32,195	30,127	31,915	29,857	33,153
Sample → Countries with above median-income at the time of the epidemic
Exposure to Epidemic (18–25)	−16.196	−11.317	0.243	−18.143	–22.066	−26.570*
	(19.432)	(20.752)	(16.352)	(11.706)	(12.233)	(13.173)
Observations	34,116	33,929	32,465	33,963	32,155	34,984

Notes: Results use the Gallup sampling weights and robust standard errors are clustered at the country level. Specification is Column 3 of Table 1.Source: Wellcome Global Monitor, 2018 and EM-DAT International Disaster Database, 1970–2017. * significant at 10%; ** significant at 5%; *** significant at 1%.